The light and dark world of aHUS
Article No. 453 25 August 2021 Recently Astra Zeneca concluded its purchase of the rare disease business unit, Alexion. $39 billion…
Article No. 453 25 August 2021 Recently Astra Zeneca concluded its purchase of the rare disease business unit, Alexion. $39 billion…
People with atypical HUS need urgent care during periods of disease activity, with treatment when needed for as long as needed.…
Article No. 451 4 August 2021 Following on swiftly from Article No. 450 about the current babble of names and need…
Article No. 4502 August 2021The more that is known,the more it seems there is to be found out. aHUS research fits…
Article No. 449 28 July 2021 It is five years on since the article below about a little girl in India…
24 Sept 2021 will mark the 7th aHUS Awareness Day. Learn more about the 2021 aHUS day project to showcase global patient experiences.
Atypical HUS Research - What's New? The aHUS Alliance Global Action team has created a virtual 'library' of publications that are aHUS-specific and are categorized by topics such as diagnosis, treatment, genetics, thrombotic microangiopathy (TMA), complement, transplant, pregnancy, and more.
Article No. 446 14 July 2021 Eculizumab effectiveness and safety in the treatment of aHUS was established in five clinical trials…
Article No. 445 13 July 2021 Hoffmann Roche has announced its pediatric trial of crovalimab for aHUS. It is featured on…